On Feb. 5, Aurora Cannabis reported its fiscal third-quarter results for the period ended Dec. 31. The cannabis company ...

As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...

Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB ...

Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...

Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.

It was a big day for Canadian cannabis stock Aurora Cannabis (TSE:ACB), as it posted its earnings report with a hefty ...

Aurora Cannabis (ACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Operator Greetings, and welcome to the Aurora Cannabis Inc. third quarter 2025 results conference call. [Operator ...

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements ...

Aurora Cannabis Inc. (NASDAQ:ACB – Get Free Report) saw unusually large options trading on Wednesday.Investors acquired 14,034 call options on the stock. This is an increase of 480% compared to ...

Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Aurora Cannabis imply an improvement in the company's underlying business. Investors should show their ...